Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases.
ZA200600038B
Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy
HK1049111A1
Synergistic compositions comprising ascorbate and lysine for states related to extra cellular matrix degeneration
MXPA04005771A
Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances.
CN1477959A
Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases
NZ512402A
Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale
IL143697D0
Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
IL140947D0
Synergistic compositions comprising ascorbate and lysine for states related to extra cellular matrix degeneration
KR20020061130A
Synergistic Compositions Comprising Ascorbate and Lysine for States Related to Extracellular Matrix Degeneration
DK200100053A
Composition for treating collagenase-linked degenerative diseases, e.g. atherosclerosis, cancer and infections, comprises ascorbate and a fibrinolysis inhibitor
MXPA01000491A
Synergetic compositions comprising ascorbate and lysine for the states related to the extracellular matrix degradation.
NZ509295A
Synergistic compositions comprising ascorbate and lysine for states related to extra cellular matrix degeneration
AU1681095A
Hydrophilic signal oligopeptides and methods of therapeutic use
AU6081094A
Synthetic oligopeptides analogous to protein signal sequences methods of identification and methods of use
